Plain-English translation of NCT07073040 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing cold atmospheric plasma (CAP) therapy as a new treatment to help heal diabetic foot ulcers that haven't responded to standard care. All participants will first receive an endovascular procedure—a minimally invasive surgery to open blocked arteries in the lower leg—which is already standard treatment. Then, half the participants will receive the new cold plasma treatment to the ulcer, while the other half receive a placebo (fake treatment), to see if this medication speeds healing and improves outcomes.
Even after doctors successfully open blocked arteries in the legs, many diabetic patients still struggle with ulcers that won't heal because blood flow to the smallest blood vessels remains poor. This trial is testing whether the new treatment can improve blood flow at the tissue level and help these difficult-to-heal wounds finally close.
You likely qualify if…
You likely don't qualify if…
First, you will undergo a minimally invasive procedure to open the blocked artery in your leg—this is standard treatment and all participants receive it. After successful artery opening, you will be randomly assigned to receive either cold plasma therapy or a placebo applied to your foot ulcer. You will then be monitored over time to see how well your ulcer heals and to track any side effects. The trial will involve follow-up visits to assess wound healing and your overall health.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China